Properties (42)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
biotechnology company
|
| gptkbp:acquisition |
biotech companies
|
| gptkbp:awards |
innovation awards
biotech awards |
| gptkbp:clinicalTrials |
Synlogic's_therapies
|
| gptkbp:collaborations |
academic institutions
research organizations |
| gptkbp:community_engagement |
educational programs
health initiatives |
| gptkbp:focus |
therapeutics
synthetic biology |
| gptkbp:founded |
2014
|
| gptkbp:founder |
gptkb:Synlogic_Founders
|
| gptkbp:headquarters |
gptkb:Cambridge,_Massachusetts
|
| https://www.w3.org/2000/01/rdf-schema#label |
Synlogic
|
| gptkbp:investmentFocus |
venture capital
public offerings |
| gptkbp:leadership |
CEO
CFO CSO |
| gptkbp:mission |
transforming lives through engineered medicines
|
| gptkbp:partnerships |
gptkb:GSK
AbbVie |
| gptkbp:patentCitation |
biotechnology patents
synthetic biology patents |
| gptkbp:platforms |
Synlogic's_platform
|
| gptkbp:publications |
conferences
peer-reviewed journals |
| gptkbp:regulatoryCompliance |
gptkb:FDA
EMA |
| gptkbp:research_focus |
cancer
inflammatory diseases metabolic diseases |
| gptkbp:sells |
SYNL
|
| gptkbp:social_responsibility |
community support
sustainability efforts |
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:supplyChain |
Synlogic-200
Synlogic-101 |
| gptkbp:technology |
engineered bacteria
|
| gptkbp:tributaryOf |
clinical pipeline
preclinical pipeline |